
Isomorphic Labs snaps $2.1B Series B to advance AI-Driven Drug Discovery
London-based Isomorphic Labs has raised $2.1 billion in a Series B funding round to accelerate the development of its AI-powered drug discovery platform and expand its therapeutic pipeline toward clinical trials.













